Australia's largest stock trading and investment forum Australia's #1 stock forum

IRX

10.7%

2.5¢ inhalerx limited

LSH TRI-POINT ‘S’ CURVE COLLISION COURSE?, page-40

First 40 Last

Share
Profile

Follow
Christian Dyor

7,133 Posts.

572

05/08/20

11:56

Post #: 46315748
Share

Originally posted by sapporo: ↑

It's the right question to ask.

Fevertel is a complete symptoms tracker, whereas from the last time I checked Kinsa was a fever tracking device.

In short, Fevertel is feature richer than its competitors, so this is the unique selling point.

To expand, the reason why this is important is fever is only one piece of the covid puzzle; other symptoms have been neglected (at least according to Dan Andrews) and people continued to go to work & spread the virus.

If a workplace has the Fevertel monitoring system, then it may notice staff are showing common symptoms, and thereby highlights the need to proactively get the staff tested & separated from other staff members as well as the public until the test results come back.

If the system were to be picked up on a much wider scale, it could become a proactive tool for the Vic government to use in its testing as there is an opt in to pool community data. That is, the Vic government will see there is an area in the community showing common non fever symptoms~ so let's check this out before it's too late.

Under the current Vic government testing system, they are 2 days behind and 2 days is too late for an enemy that it is very hard to see. This presents an opportunity for the Vic government to monitor the spread of the virus closer to real time and direct its testing in a more effective targeted manner.

The answer to your question is it a proactive solution that saves time, and saving time saves lives & $.

Imho

Expand

@sapporo thanks for your reply.

LSH Price at posting: 3.7¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 64 more messages in this thread...

First 40 Last

Add IRX (ASX) to my watchlist

(20min delay)
Last 2.5¢		Change -0.003(10.7%)		Mkt cap ! $4.744M

Open	High	Low	Value	Volume
2.5¢	2.5¢	2.5¢	$123	4.911K

Buyers (Bids)

No.	Vol.	Price($)
1	22	2.5¢

Sellers (Offers)

Price($)	Vol.	No.
2.8¢	53320	1

View Market Depth

No.	Vol.	Price($)
1	22	0.025
1	253032	0.020
1	100099	0.010
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.028	53320	1
0.030	4400	1
0.033	431682	2
0.036	130000	1
0.040	58388	1

Last trade - 10.24am 04/10/2024 (20 minute delay)

IRX (ASX) Chart

LSH TRI-POINT ‘S’ CURVE COLLISION COURSE?, page-40

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

LSH TRI-POINT ‘S’ CURVE COLLISION COURSE?, page-40

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News